A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as
Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Who Are
Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

IRB/UVA Tracking #
21795
Contact
Contact Phone
Phase
III
Primary purpose
Treatment
Cancer PI
Laahn Foster
Status
OPEN TO ACCRUAL
Ages
Adult